The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
ZEOX · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | ESTA | SRTS | ZEOX | CLDX |
|---|---|---|---|---|
| Moat Score (0–100) | 42 (highest) | 42 (highest) | 42 (highest) | 42 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 65 (highest) | 31 | 27 | 15 |
| Pricing power | 94 | 90 | 70 | 95 (highest) |
| Returns on capital | 0 | 11 (highest) | — | 0 |
| Balance-sheet safety | 28 | 55 (highest) | 28 | 55 (highest) |
| Capital discipline | 24 | 24 | 44 (highest) | 44 (highest) |
| Price vs. high estimate | No price data | 2% below high estimate | No price data | No price data |
| Market cap | $2.7B | $49.9M | $11.1M | $2.3B |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |